Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Other Non-Current Assets (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Other Non-Current Assets for 3 consecutive years, with $16942.0 as the latest value for Q3 2025.

  • Quarterly Other Non-Current Assets changed 0.0% to $16942.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $16942.0 through Sep 2025, changed 0.0% year-over-year, with the annual reading at $16942.0 for FY2024, 0.0% changed from the prior year.
  • Other Non-Current Assets hit $16942.0 in Q3 2025 for Mangoceuticals, roughly flat from $16942.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $177858.0 in Q1 2023 to a low of $16942.0 in Q2 2023.
  • Historically, Other Non-Current Assets has averaged $31570.7 across 3 years, with a median of $16942.0 in 2023.
  • Biggest YoY gain for Other Non-Current Assets was 0.0% in 2024; the steepest drop was 90.47% in 2024.
  • Year by year, Other Non-Current Assets stood at $16942.0 in 2023, then changed by 0.0% to $16942.0 in 2024, then changed by 0.0% to $16942.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for MGRX at $16942.0 in Q3 2025, $16942.0 in Q2 2025, and $16942.0 in Q1 2025.